O valor de publicar-se resultados negativos de ensaios clínicos randomizados: o estudo de Rosenheck
Lima, Maurício Silva de; Soares, Bernardo Garcia de Oliveira.
Braz. J. Psychiatry (São Paulo, 1999, Impr.)
; 26(2): 135-135, jun. 2004.
Artigo em Português | LILACS | ID: lil-385237
Documentos relacionados
Publication Bias in Trials With and Without Null Findings-Reply.
Psychedelic Psychiatry's Brave New World.
Characterization of discontinuation and nonpublication of phase III randomized clinical trials of psoriasis.
Effects of exogenous melatonin supplementation on health outcomes: An umbrella review of meta-analyses based on randomized controlled trials.
In reply: A two-stage review process for randomized controlled trials: the ultimate solution for publication bias?
The need for publishing the silent evidence from negative trials.
Plant-based Medicines (Phytoceuticals) in the Treatment of Psychiatric Disorders: A Meta-review of Meta-analyses of Randomized Controlled Trials: Les médicaments à base de plantes (phytoceutiques) dans le traitement des troubles psychiatriques: une méta-revue des méta-analyses d'essais randomisés contrôlés.
Ethical questions in human clinical psychopharmacology: should the focus be on placebo administration?
Evidence of publication bias in multiple sclerosis clinical trials: a comparative analysis of published and unpublished studies registered in ClinicalTrials.gov.
Randomized controlled trials of rheumatoid arthritis registered at ClinicalTrials.gov: what gets published and when.